Provided by Tiger Fintech (Singapore) Pte. Ltd.

HBM HOLDINGS-B

9.470
-0.200-2.07%
Volume:4.63M
Turnover:43.58M
Market Cap:7.82B
PE:333.62
High:9.650
Open:9.650
Low:9.250
Close:9.670
Loading ...

Harbour BioMed Announces Phase II Clinical Data Presentation of HBM4003 and Tislelizumab Combo for MSS Metastatic Colorectal Cancer at ESMO 2025

Reuters
·
30 Jul

CICC Starts HBM Holdings at Outperform with HK$13.40 Price Target

MT Newswires Live
·
29 Jul

HBM Forecasts Up to HK$579 Million in H1 Profit; Shares Slip 4%

MT Newswires Live
·
28 Jul

BRIEF-HBM Holdings Expects HY Profit Between $68 MLN & $74 MLN

Reuters
·
28 Jul

HBM Holdings Ltd. Projects Profits to Surge Up to US$74 Million in Positive Profit Alert

Reuters
·
28 Jul

Hbm Holdings Ltd - Expected Result Due to Strategic Partnerships With AstraZeneca, Others in Hy

THOMSON REUTERS
·
28 Jul

Hbm Holdings - Expects Profit Between US$68 Mln and US$74 Mln in Hy

THOMSON REUTERS
·
28 Jul

HBM Holdings Ltd. Announces Global Phase 2 POLARIS Trial for Long-Acting Anti-TSLP Antibody in Asthma

Reuters
·
23 Jul

Hbm Holdings Ltd - Windward Bio Plans Global Copd Trials in 2026

THOMSON REUTERS
·
23 Jul

Hbm Holdings Ltd - Phase 2 Trial Data for Hbm9378/Win378 Expected Mid-2026

THOMSON REUTERS
·
23 Jul

Hbm9378/Win378, a Long-Acting, Fully Human Anti-Tslp Antibody, Enters Global Phase 2 Polaris Trial for Asthma

THOMSON REUTERS
·
23 Jul

HBM Holdings Ltd. Files Disclosure with HKEX Announcing Repurchase of 300,000 Shares at HKD 7.7601 Each

Reuters
·
11 Jul

HBM Holdings Subsidiary, HBM Shanghai, Backs NK Cell-Tech's A+++ Financing Round

Reuters
·
09 Jul

HBM Holdings Ltd. Files Next Day Disclosure Return to HKEX, Announcing Repurchase of 2.3 Million Shares at HKD 818,300

Reuters
·
07 Jul

HBM Holdings Ltd. Announces New Share Option Grant Plan for Employees

Reuters
·
02 Jul

HBM Holdings Ltd. Files Next Day Disclosure to HKEX Announcing Repurchase of 300,000 Shares at HKD 8.1738 Each

Reuters
·
27 Jun

HBM Holdings Ltd. Files Next Day Disclosure Return to HKEX, Announces Repurchase of 1,900,000 Shares at HKD 8.6822 Each

Reuters
·
25 Jun

BRIEF-HBM Holdings Says Strategic Collaboration With Otsuka For HBM7020

Reuters
·
23 Jun

HBM Holdings Ltd. Enters Global Strategic Partnership with Otsuka Pharmaceutical for HBM7020 Development

Reuters
·
23 Jun

HBM Holdings Ltd. Files Next Day Disclosure Return to HKEX, Announces Repurchase of 200,000 Shares at HKD 7.7777 Each

Reuters
·
19 Jun